Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Profit Margin
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin.
The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.11%. TRIB's revenue for the same period is $79.32 million.
The trailing-twelve-month profit margin at Meridian Bioscience Inc (NASDAQ: VIVO) is 17.59%. VIVO's PEG ratio is 1.27.
The trailing-twelve-month profit margin at Neogen Corp (NASDAQ: NEOG) is 12.53%. NEOG's operating margin for the same period is 18.75%.
The trailing-twelve-month profit margin at Abaxis Inc (NASDAQ: ABAX) is 8.36%. ABAX's ROE for the same period is 7.97%.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Tags: Diagnostic Substances Industry, Highest Profit Margin, small-cap
Posted in: Trading Ideas